![[AlzTalks-Archive] What Matters Most in an Alzheimer's Treatment? Dr. Brett Hauber Artwork](https://www.buzzsprout.com/rails/active_storage/representations/redirect/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaHBBNUNvQnc9PSIsImV4cCI6bnVsbCwicHVyIjoiYmxvYl9pZCJ9fQ==--876aa4245eddc212ea9d7a747d6c5b14e641c7c4/eyJfcmFpbHMiOnsibWVzc2FnZSI6IkJBaDdDVG9MWm05eWJXRjBPZ2hxY0djNkUzSmxjMmw2WlY5MGIxOW1hV3hzV3docEFsZ0NhUUpZQW5zR09nbGpjbTl3T2d0alpXNTBjbVU2Q25OaGRtVnlld1k2REhGMVlXeHBkSGxwUVRvUVkyOXNiM1Z5YzNCaFkyVkpJZ2x6Y21kaUJqb0dSVlE9IiwiZXhwIjpudWxsLCJwdXIiOiJ2YXJpYXRpb24ifX0=--1924d851274c06c8fa0acdfeffb43489fc4a7fcc/Hauber_Brett_headshot.jpg)
BrainStorm by UsAgainstAlzheimer's
BrainStorm, a podcast series by UsAgainstAlzheimer’s, features conversations with doctors, researchers, authors and luminaries, people living with dementia and their caregivers. We’ll delve into what matters most to you about your brain and ask questions about keeping your memory sharp and maintaining optimal brain health. Learn about the latest in the science of longevity, Alzheimer’s and cognitive disease research. We’ll look at disparities in diseases, and equity and access for all. New episodes, hosted by Meryl Comer, are available first and third Tuesdays of every month. Join Us!
BrainStorm by UsAgainstAlzheimer's
[AlzTalks-Archive] What Matters Most in an Alzheimer's Treatment? Dr. Brett Hauber
•
UsAgainstAlzheimer's
•
Season 7
•
Episode 5
BrainStorm wants to hear from you! Send us a text.
Does research into new Alzheimer's treatments reflect what matters most to those living with the disease and their care partners? When new drugs become available, will they address the symptoms and make the changes in people’s lives that are most important to them? Researcher Brett Hauber of RTI Health Solutions discusses the new What Matters Most Study. UsAgainstAlzheimer’s and its partners are launching this study to learn what matters most to those living with Alzheimer’s, so that insights from those with Alzheimer's and their care partners are considered as drugs are developed, approved, and brought into patient’s lives.